SEMA4D and neoplasm: In vivo experiment, we transplanted B16-F10R cells in the mice and observed the size and weight of tumors treated with nivolumab, tumor volume and weight were significantly delayed in Sema4D-shRNA group mice as compared to Sema4D-NC group mice (Figs. 3F, 3G and 3H).